Skip To Main Content
Sung-Soo Yoon on Muck Rack

Sung-Soo Yoon

As seen in: Nature, Wiley Online Library, MDPI, Biomed Central (BMC), Genome Medicine, Physician's Weekly
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sung-Soo

Contact Sung-Soo, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Response kinetics as a dynamic prognostic marker in patients with multiple myeloma

|
By Hee Jeong Cho, Myung-Won Lee, Jae Lee, Hyeon-Seok Eom, Jongheon Jung, Ho-Young Yhim, Dok Hyun Yoon, Hyungwoo Cho, Sung-Soo Yoon, Ja Min Byun, Young Rok Do, Hyo Jung Kim, Ji Hyun Lee, Sung-Nam Lim, Hye Jin Kang, Ho Sup Lee, Yundeok Kim, Hee Jeong Lee, Sang Lee, Kihyun Kim, Joon Moon
| Nature Verified
Open in Who Shared Issue with article?

Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003) | Blood Cancer Journal

|
By Jin Kim, C. S. Chim, Je-Jung Lee, Sung-Soo Yoon, Hiroshi Handa, Sanjay de Mel
| Nature Verified
Abstract Pomalidomide has been shown to improve survival in patients with relapsed/refractory myeloma (RRMM). However, the optimal pomalidomide-based combinations in RRMM are not known. This study compared pomalidomide, cyclophosphamide, dexamethasone (PCD) with pomalidomide and dexamethasone (PD) in Asian patients with RRMM. Patients were randomly assigned to receive PCD or PD.
Open in Who Shared Issue with article?

Romiplostim with ciclosporin A in patients with aplastic anaemia naïve to immunosuppressive therapy: A phase 2/3 study

|
By Jong Wook Lee, Jun Ho Jang, Shigeru Chiba, Sung-Soo Yoon
| Wiley Online Library Verified
CONFLICT OF INTEREST STATEMENT JWL received grants or contracts from Alexion Pharmaceuticals, Inc. and Kyowa Kirin Co., Ltd.; consulting fees from Alexion Pharmaceuticals, Inc., Kyowa Kirin Co., Ltd. and Sanofi K.K.; and payment or honoraria from Alexion Pharmaceuticals, Inc., Kyowa Kirin Co., Ltd. and Sanofi K.K. SC received grants or contracts from Kyowa Kirin Co., Ltd., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Astellas Pharma Inc.
Open in Who Shared Issue with article?
See all 11 licensed articles (12 Total)